Welcome subscribers,
In this edition, we examine sustainability initiatives in life sciences real estate, highlighting the key areas of energy consumption, water usage and embodied carbon. Additionally, we cover new builds, sales, and leasing activities across Europe. Keep reading!
✅ Estonia: new factory for PharmaPark
✅ Ireland: DCU Alpha seeks strategic partner
✅ Germany: light bulb moment at Osram campus
✅ UK: Clarion Partners invests in Warrington
Read more below for all the details.
Eco-friendly labs: advancing sustainability in life sciences buildings
Sustainability initiatives in life sciences buildings focus on energy, water and embodied carbon
Read the full articleA message from our sponsor Backbone Connect:
Was this email forwarded to you? Did you know that you can subscribe to Life Sciences Real Estate and get access to all our resources?
New and extended assets
ESTONIA TALLINN
The Estonian-Dutch joint venture PharmaPark inaugurated one of Europe’s largest veterinary medicine factories on 24 May in Tallinn. The investment amounts to €50 million (£42 million) and output is largely for export through the Dutch partner’s channels. The PharmaPark factory is located near Tallinn Airport on Nuia Street, in a building that extends to 21,000 sq m (226,000 sq ft). The building includes microbiology and analytical chemistry laboratories, production and warehouse spaces, and office areas. PharmaPark currently employs 35 people.
FRANCE LYON
In Lyon Gerland, Sanofi is investing €10 million ($10.9 million) to locate the production of TZIELD® in France. This is a biologic for type 1 diabetes that Sanofi acquired in April 2023 and which has been manufactured outside Europe. The production site is located in the heart of the Lyon life sciences ecosystem (the Biodistrict) and hosts over 370 Sanofi employees.
GERMANY RAVENSBURG
The Ravensburg pharmaceutical company Vetter is planning a production site in Saarlouis, using large parts of the Ford site there. The plot has not yet been sold, but state county Saarland has secured access to it by means of a binding reservation of ownership. At the same time, plans are underway for the separation of the infrastructure on the site. This involves around 50 hectares (124 acres) on which a new technology park is to be built. Vetter plans to invest several hundred million euros and to create up to 2,000 jobs in the coming years. Production will start in 2030. Vetter has a presence in Ravensburg and Langenargen.
IRELAND DUBLIN
Dublin City University (DCU) will seek a strategic partner to build out its innovation campus; proposals will be sought in the second half of 2024. DCU Alpha, as the innovation campus is known, comprises 23,250 sq m (250,000 sq ft) of repurposed office and lab space across ten buildings and it is fully occupied, housing over 50 companies and 650 employees. Tenants include fast-scaling indigenous tech businesses, university spinouts, and early-stage start-ups across several science and tech sectors including medtech. The new phase of DCU Alpha will see the development of up to 46,500 sq m (500,000 sq ft) of sci-tech real estate, aimed at showcasing DCU research and creating a world-class innovation ecosystem.
IRELAND DUBLIN
Experic, a contract development and manufacturing organisation (CDMO) and clinical trial supplier, will open a new 930 sq m (10,000 sq ft) warehouse providing monitored storage and logistics services, including cold storage and re-labelling capabilities, in the second half of 2024. The new site will support pharmaceutical companies conducting global clinical trials with investigator sites and patients across Europe. This is the company's first physical expansion into the EU.
UK OXFORD
Earlier this year Kadans Science Partner completed Barton House at Abingdon Science Park. Barton House contains 25,600 sq ft (2,400 sq m) of purpose-built laboratory accommodation for researchers and can be offered as a Cat A product or as a fully bespoke, fitted laboratory and office accommodation.
